Michigan Medical P.C. Neurology

Grand Rapids, Michigan 49525

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting

Studies at this site

• A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis — Completed
• Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis — Completed